About: TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 August 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu n'agostu de 2018 (ast) scientific article published on 31 August 2018 (en)
publication date	wds:Q91254982-A7EAAB58-7A3C-4D01-96F6-DCA2EC9A634E
publication date	2018-08-31 00:00:00Z (xsd:dateTime)
author name string	wds:Q91254982-21B4D226-52EF-48CE-BD35-272FD7510CCD wds:Q91254982-2B450939-5417-42D9-A036-3068CEBBCEE7 wds:Q91254982-3C6CB4E7-9143-4A13-A0E5-DF462255F911 wds:Q91254982-468C9BC5-438A-4622-98A9-55D19FE1D899 wds:Q91254982-6436CF7A-0ACC-4B0E-AAC5-5A9D97834F09 wds:Q91254982-6C0A678C-075F-4A40-817B-20DFA51AD842 wds:Q91254982-98FD89D1-9849-4328-A4EA-91885A8C2762 wds:Q91254982-A59F1CD1-9642-4971-9E69-385BDC681ADC wds:Q91254982-AE834E35-18B3-4E08-AD7B-432660DEC81F wds:Q91254982-B06EBA64-5B06-43A5-97ED-789F1873CDBE wds:Q91254982-B3538200-535D-4571-8B08-3BC1000A7617 wds:Q91254982-C58846A5-23A4-4A4B-AB8E-D6D0AF44F3E0 wds:Q91254982-CA9C145A-3863-44FC-BDA6-76E0AB6EB9C4
author name string	Marco Biolato Massimo Siciliano Michele Basso Riccardo Manfredi Felice Giuliante Eleonora Annicchiarico Lucia Cerrito Francesca Carchesio Alessandro Posa AnnaMaria De Gaetano Francesca Ponziani GianLodovico Rapaccini HepatoCatt Study Group
rdfs:label	TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (en) TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (nl)
skos:prefLabel	TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (en) TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (nl)
name	TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (en) TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (nl)
author	wds:Q91254982-099E1404-3EFD-4B7C-A73F-2DE05A59B0E8 wds:Q91254982-2A10FF9C-C15E-4CB0-847E-82918C7BB42E wds:Q91254982-2D089188-EF51-4560-B09F-A325A1721BB4 wds:Q91254982-5BDE2F89-1CD1-49CD-A044-07AE72E2A935 wds:Q91254982-7DAF2946-C57F-475E-868F-D7E41F21AA43 wds:Q91254982-E7870D64-6E6F-4DDC-906A-2AC8E197735E
author	Antonio Gasbarrini Maurizio Pompili Emanuele Rinninella Matteo Garcovich Maria Assunta Zocco Roberto Iezzi
title	wds:Q91254982-8C7615CB-31AC-430E-B952-21101F52531E
title	TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (en)
page(s)	wds:Q91254982-70F3428F-A22E-428B-8A0D-F3DF72C9714D
page(s)	1285-1292
instance of	wds:Q91254982-ACB76F7C-95E8-4A1B-9B6E-A366D10219AA
instance of	scholarly article
main subject	wds:Q91254982-5AEC5632-5062-4F7A-9B04-FC1D417E36CE wds:Q91254982-95063E6B-2D04-493F-9C21-1BD91E70B81B
main subject	hepatocellular carcinoma microsphere
PubMed ID	wds:Q91254982-58FAF35F-06ED-43FB-B3C8-75F323164673
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30171360
PubMed ID	30171360
published in	wds:Q91254982-8E0E923F-DEF0-40AA-B6EC-197B0B84A45E
published in	European Radiology
issue	wds:Q91254982-54703175-46CE-437A-B68C-5A18421A9C29
volume	wds:Q91254982-D09F22E3-1D5E-435B-A995-2B7FD15ABB08
issue	3
volume	29
DOI	wds:Q91254982-044AF1FA-6637-4858-853C-7648650819DA
DOI	http://dx.doi.org/10.1007/S00330-018-5692-8
DOI	10.1007/S00330-018-5692-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91254982
is cites work of	Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus
is cites work of	wds:Q89849789-87D42025-37E9-4E40-A77A-FC438268DD66 wds:Q90136078-9C6B0B99-5567-4BB1-924D-14824B7CE473

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software